New guidelines developed help improve the use of liver blood tests in patients with liver disease. These guidelines can also prevent unnecessary repetition of tests, reveals a new study. The study was led by experts at the University of Birmingham and the recommendations were published in Gut. While the number of deaths from other common conditions is falling in the UK, those due to liver disease have been increasing dramatically, with a 400 percent increase in death rates between 1970 and 2010. Death rates due to liver disease has also risen sharply in younger people, with a 500 percent increase in the same period for those aged under 65. ‘New guidelines give the definitions for abnormal blood tests and advise to patients with liver disease, as to when the liver blood tests should be done.’ Lead author Professor Philip Newsome, Director of the Centre for Liver Research at the University of Birmingham's Institute of Immunology and Immunotherapy, said: "Liver disease develops silently; there may be no signs or symptoms until the complications of liver failure develop. "Since the current liver blood tests were developed in the 1950s, they have been the mainstay of liver disease identification. Unfortunately the way liver blood tests are interpreted means that many patients with liver disease are not identified until at a late stage. "Liver blood or function tests are checked ever more frequently in both primary and secondary care in an attempt to exclude liver disease, for the monitoring of potential adverse effects of drugs on the liver such as statins, and for the investigation of the generally unwell patient. "These tests often produce an abnormal result, the clinical significance of which is unclear. "In many cases they are requested in response to non-specific symptoms where there is little potential link between symptoms and likelihood of liver disease, or the blood tests are performed for unrelated reasons such as chronic disease monitoring. "This frequently leads to a cycle of additional liver blood test testing in an otherwise asymptomatic individual. Notably, many patients referred to hospital with abnormal liver tests do not have any evidence of significant liver disease." The new guidelines, which cover both adults and children, recommend that initial investigation in patients with potential liver disease should include bilirubin, albumin, ALT, alkaline phosphatase (ALP) and gamma-glutamyltransferase (GGT) plus a complete blood count. They also include definitions for 'abnormal' blood tests and advise when patients should have liver blood tests, as well as offering advice on pathways and tools for managing patients with abnormal test results. Professor Newsome adds, "The pathways will be freely disseminated and should be incorporated into primary care IT systems to allow automatic calculation of risk scores when appropriate, to ensure recommendations can be put into practice." They also state that research is needed to establish the most cost-effective approach to identify patients with alcohol-related liver disease and non-alcoholic fatty liver disease at risk of having advanced liver fibrosis. The recommendations now supersede earlier guidelines in 2000 and were commissioned by the Clinical Services and Standards Committee of the British Society of Gastroenterology.Source: Eurekalert << Power of Sperm Motility can be Harnessed to Deliver Drugs Blood Pressure Drugs may extend the Lifespan of Roundworms >> Recommended Reading Coffee Consumption Lowers Risk of Liver Disease New report on coffee and liver health discusses potential impact of coffee consumption on chronic liver disease, liver cancer and cirrhosis READ MORE Our Chairs are Slowly Killing Us As Prolonged Sitting Is Linked With Fatty Liver Disease Our body is designed to move and it is not surprising that sedentary behavior, characterized by low muscle activity, has a direct impact on physiology. READ MORE Enzyme Produced in the Liver Can Treat Fatty Liver Disease DPP4 inhibitors are usually given for type 2 diabetes. These inhibitors not only improve the sugar metabolism, but can also treat non-alcoholic fatty liver disease. READ MORE New Algorithm to Predict Type of Treatment in Liver Disease The algorithm allows physicians to help determine patients who are likely to benefit from intensive care unit treatment. READ MORE Alcoholic Liver Disease Encyclopedia section of medindia gives general information about Alcoholic Liver Disease. READ MORE Biliary Cirrhosis Biliary cirrhosis occurs due to obstruction to the flow of bile through bile ducts either within the liver or outside the liver. READ MORE Current Treatments for Liver Cancer Current Treatments for Liver Cancer (also known as hepatoma or hepatocellular carcinoma) can result in complete cure of the disease if it is detected early. READ MORE Fatty Liver Disease: A Growing Health Problem in India Non alcoholic fatty liver disease (NAFLD) is the leading cause of liver dysfunction worldwide and is a rapidly growing health problem in India. READ MORE Hepatitis A Hepatitis A is the most benign of the hepatitis viruses and usually has no long term side effects. Hepatitis A vaccine is available that is 95% effective in preventing the disease. READ MORE Living Donor Liver Transplant: What Are the Risks? The risk of dying as a result of a living donor liver segment removal is between 0.2-2.0%. The risk of morbidity is anywhere between 1.3% (in highly experienced centers) to 60%. READ MORE Milk Thistle Milk Thistle is a resourceful natural plant which has many medicinal benefits. In herbal medication milk thistle is used in cases of liver diseases. READ MORE Wilson's Disease This is a rare inherited systemic disorder of copper metabolism, affecting the liver mainly before other organs. READ MORE Most Popular on Medindia Blood Pressure Calculator Drug Side Effects Calculator A-Z Drug Brands in India More News on: Alcoholic Liver DiseaseLiver BiopsyHepatitis ALiverWilson's DiseaseBiliary CirrhosisMilk ThistleCurrent Treatments for Liver CancerFatty Liver Disease: A Growing Health Problem in IndiaLiving Donor Liver Transplant: What Are the Risks?